Due to the rapidly changing landscape of the pharmaceutical industry, maximizing influence within the market remains of utmost importance. Both Key Opinion Leaders (KOLs) and Digital Opinion Leaders (DOLs) serve as surrogates of information to healthcare professionals and heavily shape the behavior of individuals and groups in the pharmaceutical industry.
Neolytica aims to provide advanced data analytics solutions to pharmaceutical, biotech, and medical device companies. Leveraging artificial intelligence and machine learning technologies, Neolytica offers actionable insights and predictive analytics to drive informed decision-making and optimize business strategies in the rapidly evolving healthcare landscape.
Morristown, NJ – March 17, 2022 – Neolytica, a healthcare analytics firm, today announced that it has experienced explosive business growth over the past year. The company has added numerous enterprise-level customers to its roster, and now counts 12 of the top 20 pharmaceutical companies among its clients.
The company aims to provide customized solutions for key opinion leader (KOL) identification and mapping, help medical and commercial teams collaborate, and improve medical education within biopharma companies.
